92 results
Page 2 of 5
8-K
gjlyb5m809wkfgjms0c
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-10.2
85mg cixu425zsxxbo
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
9d06x
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
424B5
f4jr5t0jh63zwtyxzb
29 Sep 22
Prospectus supplement for primary offering
4:08pm
424B5
3xhat914f04ewmni
27 Sep 22
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
dhaa0bnqs6w277
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
22hq2 jrj5p
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
424B7
c0gbht1q35fs5dy52v
14 Jun 22
Prospectus with selling stockholder info
4:26pm
8-K
EX-99.1
p8f6lmdp
2 Jun 22
Gamida Cell Completes
7:31am
POS AM
EX-5.1
6ce 2dhc5ow
1 Jun 22
Prospectus update (post-effective amendment)
4:56pm
POS AM
c3445
1 Jun 22
Prospectus update (post-effective amendment)
4:56pm
10-Q
g849a7t6
12 May 22
Quarterly report
7:42am
8-K
EX-99.1
q2quasz8yr7dnclitw
10 May 22
Gamida Cell Reports First Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
plj1wz2 notwi5
26 Apr 22
Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201
7:30am
10-K
uoa2uscsfq4wyiye4dh
24 Mar 22
Annual report
7:30am
8-K
EX-99.1
bti qt2l5aa8
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am
6-K
EX-99.1
f5v4he7
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
EX-99.2
7exukyh2v1e7
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am